Aeglea BioTherapeutics, Inc. AGLE announced a corporate restructuring plan to focus resources and prioritize the development of its pipeline candidate, AGLE-177 for the treatment of patients living ...
Aeglea Biotherapeutics (AGLE) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
Aeglea BioTherapeutics AGLE completed its acquisition of Spyre Therapeutics, Inc., a privately held company focused on developing antibody therapeutics for inflammatory bowel disease (IBD). Shares of ...
Zee TV's 'Agle janam Mohe Bitiya Hi Kijo', created waves across India for showcasing a prevalent social evil in society. The concept of 'selling the girl child amidst utter poverty to raise money for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback